Supernus Announces Fourth Quarter and Full Year 2022 Financial Results
Go back to Supernus Announces Fourth Quarter and Full Year 2022 Financial Results| SUPERNUS PHARM (NASDAQ: SUPN) | Delayed: 42.92 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.92 | 52 Week High | $26.84 | |||
| Open | $42.92 | 52 Week Low | $9.51 | |||
| Day High | $42.92 | P/E | N/A | |||
| Day Low | $42.92 | EPS | $-2.62 | |||
| Volume | 265 | |||||

